OpenAI GPT-Rosalind model for life sciences research
US 17 avr. 2026Signal de tendance
11
mentions (7j)
11
mentions (30j)
17 avr. 2026
premier signal
1
pays concernés
Contexte et analyse
Cette tendance "OpenAI GPT-Rosalind model for life sciences research" a été détectée dans la catégorie Intelligence Artificielle avec un score de 100/100. Cette tendance connaît une croissance explosive et attire beaucoup d'attention actuellement.
Entités liées
Ce que disent les sources
"OpenAI released GPT‑Rosalind, an AI model optimized with enhanced biology knowledge and capabilities for life sciences research."
"OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research..."
"April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities,..."
"OpenAI announced a new series of AI models built to help life sciences researchers work faster. Why it matters: Biology research is increasingly..."
"The journey from a laboratory hypothesis to a pharmacy shelf is one of the most grueling marathons in modern industry, typically spanning 10 to 15 years and..."
"OpenAI became the latest tech giant to launch a life sciences-focused AI offering, aiming to build a biopharma business."
"OpenAI just announced GPT-Rosalind, a new specialized AI model built exclusively for life sciences research. The model is named in honor of the pioneering..."
"OpenAI announced the launch of a new series of artificial intelligence models designed to support researchers in the life sciences and to accelerate their..."
"OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a field of growing interest for tech..."
"HelixGen AI has launched GPT-Rosalind, a large language model built specifically for life sciences research, trained on 200 billion tokens from scientific."
"The GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug discovery and..."